Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16th annual PEACe Conference Bruker Cellular Analysis is pleased to announce that GSK will present data on the SpotLightâ„¢ Human Lambda reagent for the Beacon® platform at the 16th annual Conference on Protein Expression in Animal Cells, which is being held in Sitges, Spain from September …
Explore Announcement Articles
In a significant development, we are pleased to introduce Meteorâ„¢ chips on the IsoSparkâ„¢ platform, marking a major step forward in high-throughput, quantitative, and automated bulk proteomics. This advancement promises to simplify research processes and expedite scientific progress. Meteor chips on the IsoSpark platform: The Advantages Automated Analysis and User-Friendly Meteor chips simplify proteomic workflows. …
As next-generation precision medicine grows, so does the need for broader accessibility to cutting-edge technologies. To meet this demand, Bruker Cellular Analysis has introduced the Beacon Questâ„¢ optofluidic system, a two-chip optofluidic system that features Opto T Cell Profiling workflows for immunotherapy translational research, Opto Plasma B Discovery workflow and Opto Memory B Discovery workflows …
With the coming together of Berkeley Lights and IsoPlexis, Bruker Cellular Analysis is positioned to power labs across the new frontier of biological and medicinal research. We are uniquely enabling the exploration of the phenome and mastery of single cells for all labs and scientists. Our platform now powers all stages across the discovery and …
Bruker Cellular Analysis: Driving the Next Wave of Biological Breakthroughs Read More »